{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:28:45Z","timestamp":1790494125212,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.vaccine.2014.09.024","type":"journal-article","created":{"date-parts":[[2014,9,21]],"date-time":"2014-09-21T22:20:36Z","timestamp":1411338036000},"page":"6240-6250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["HBHA vaccination may require both Th1 and Th17 immune responses to protect mice against tuberculosis"],"prefix":"10.1016","volume":"32","author":[{"given":"Claudie","family":"Verwaerde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Debrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Dombu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Raze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Betbeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Locht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.09.024_bib0005","series-title":"Weekly epidemiological record","first-page":"509","volume":"86","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis\u2014meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2014.09.024_bib0020","doi-asserted-by":"crossref","first-page":"e1002607","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against tuberculosis: where are we and where do we need to go","volume":"8","author":"Ottenhoff","year":"2012","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.1016\/j.vaccine.2014.09.024_bib0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2012.03.004","article-title":"Tuberculosis vaccine development: strength lies in tenacity","volume":"33","author":"Kaufmann","year":"2012","journal-title":"Trends Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2014.09.024_bib0030","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.5588\/ijtld.12.0569","article-title":"A rational vaccine pipeline for tuberculosis","volume":"16","author":"Brennan","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0035","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.184.3.993","article-title":"Identification of a heparin-binding hemagglutinin present in mycobacteria","volume":"184","author":"Menozzi","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0040","doi-asserted-by":"crossref","first-page":"10759","DOI":"10.1073\/pnas.162246899","article-title":"Mycobacterial heparin-binding hemagglutinin and laminin-binding protein share antigenic methyllysines that confer resistance to proteolysis","volume":"99","author":"Pethe","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/35084083","article-title":"The heparin-binding haemagglutinin of Mycobacterium tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0050","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1086\/338833","article-title":"Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis","volume":"185","author":"Masungi","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0055","doi-asserted-by":"crossref","first-page":"e43285","DOI":"10.1371\/journal.pone.0043285","article-title":"Risk stratification of latent tuberculosis defined by combined interferon gamma release assays","volume":"7","author":"Corbi\u00e8re","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0060","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.micinf.2009.07.005","article-title":"Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis","volume":"11","author":"Rouanet","year":"2009","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0065","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1128\/IAI.72.12.6799-6805.2004","article-title":"The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis","volume":"72","author":"Parra","year":"2004","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2014.09.024_bib0070","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1128\/JVI.80.10.4962-4970.2006","article-title":"Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers","volume":"80","author":"Stephenson","year":"2006","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2014.09.024_bib0075","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s11095-011-0624-1","article-title":"Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells","volume":"29","author":"Chang","year":"2012","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0080","first-page":"126e33","article-title":"Positively charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as \u2018stealth\u2019 cationic nanocarriers","volume":"27","author":"Paillard","year":"2007","journal-title":"Pharm Res"},{"issue":"Dec (35)","key":"10.1016\/j.vaccine.2014.09.024_bib0085","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1016\/j.biomaterials.2012.08.064","article-title":"Influence of surface charge and inner composition of nanoparticles on intracellular delivery of proteins in airway epithelial cells","volume":"33","author":"Dombu","year":"2012","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.vaccine.2014.09.024_bib0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-3083.2006.01791.x","article-title":"Influence of high-fat feeding on both naive and antigen-experienced T-cell immune response in DO10.11 mice","volume":"64","author":"Verwaerde","year":"2006","journal-title":"Scand J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2014.09.024_bib0095","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.4049\/jimmunol.1002348","article-title":"Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia","volume":"186","author":"Paget","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0100","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4049\/jimmunol.164.3.1617","article-title":"Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo","volume":"164","author":"Hartmann","year":"2000","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2014.09.024_bib0105","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1128\/IAI.69.8.4816-4822.2001","article-title":"Protection of BALB\/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant","volume":"69","author":"Al-Mariri","year":"2001","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2014.09.024_bib0110","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20020147","article-title":"Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection","volume":"195","author":"Rhee","year":"2002","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2014.09.024_bib0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1742-4933-10-25","article-title":"Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG","volume":"10","author":"Taniguchi","year":"2013","journal-title":"Immun Ageing"},{"issue":"4","key":"10.1016\/j.vaccine.2014.09.024_bib0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2014.09.024_bib0125","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1128\/IAI.01392-09","article-title":"Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon","volume":"78","author":"Wozniak","year":"2010","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2014.09.024_bib0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00281-009-0191-2","article-title":"Th17 cytokines and vaccine induced immunity","volume":"32","author":"Lin","year":"2010","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-065X.2008.00703.x","article-title":"Th17 cytokines and mucosal immunity","volume":"226","author":"Dubin","year":"2008","journal-title":"Immunol Rev"},{"issue":"11","key":"10.1016\/j.vaccine.2014.09.024_bib0140","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.4049\/jimmunol.0901144","article-title":"Intranasal immunization promotes Th17 immune responses","volume":"183","author":"Zygmunt","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2010.11.002","article-title":"The role of Th17 cytokines in primary mucosal immunity","volume":"6","author":"Kolls","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0150","doi-asserted-by":"crossref","first-page":"12625","DOI":"10.1073\/pnas.95.21.12625","article-title":"Molecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesin","volume":"95","author":"Menozzi","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2014.09.024_bib0155","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.vaccine.2014.09.024_bib0160","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0165","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/S0264-410X(02)00191-3","article-title":"Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses","volume":"20","author":"Debin","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0170","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jps.21065","article-title":"The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles","volume":"97","author":"Malyala","year":"2008","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.vaccine.2014.09.024_bib0175","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/10611860903119656","article-title":"Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response","volume":"17","author":"Fischer","year":"2009","journal-title":"J Drug Target"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.addr.2008.12.013","article-title":"Innovative strategies for co-delivering antigens and CpG oligonucleotides","volume":"61","author":"Krishnamachari","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0185","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.addr.2008.12.010","article-title":"The immunogenicity of CpG\u2013antigen conjugates","volume":"61","author":"Wagner","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10.1016\/j.vaccine.2014.09.024_bib0190","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.4049\/jimmunol.148.12.4072","article-title":"Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural-killer activity","volume":"148","author":"Yamamoto","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0195","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/eji.1830270931","article-title":"CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants","volume":"27","author":"Lipford","year":"1997","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.09.024_bib0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.0105-2896.2004.00148.x","article-title":"Use of CpG oligodeoxynucleotides as immune adjuvants","volume":"199","author":"Klinman","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0205","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.addr.2008.12.012","article-title":"CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases","volume":"61","author":"Klinman","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2014.09.024_bib0210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.immuni.2008.03.001","article-title":"Th17 cell differentiation: the long and winding road","volume":"28","author":"McGeachy","year":"2008","journal-title":"Immunity"},{"issue":"4 (Suppl 1)","key":"10.1016\/j.vaccine.2014.09.024_bib0215","first-page":"A","article-title":"CpG oligonucleotide stimulation of TLR9 inhibits IL-17 production from mesenteric lymph node cells","volume":"134","author":"Metwali","year":"2008","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.vaccine.2014.09.024_bib0220","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.4049\/jimmunol.0803842","article-title":"TLR signals promote IL-6\/IL-17-dependent transplant rejection","volume":"182","author":"Chen","year":"2009","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2014.09.024_bib0225","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.4049\/jimmunol.0900645","article-title":"Encephalitogenicity of complete Freund's adjuvant relative to CpG is linked to induction of Th17 cells","volume":"183","author":"Tigno-Aranjuez","year":"2009","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2014.09.024_bib0230","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1128\/IAI.00580-09","article-title":"Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion","volume":"77","author":"da Fonseca","year":"2009","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2014.09.024_bib0235","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2567.2007.02597.x","article-title":"Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection","volume":"121","author":"da Fonseca","year":"2007","journal-title":"Immunology"},{"issue":"40","key":"10.1016\/j.vaccine.2014.09.024_bib0240","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1016\/j.vaccine.2011.07.039","article-title":"Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis","volume":"29","author":"Ballester","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2014.09.024_bib0245","doi-asserted-by":"crossref","first-page":"e63344","DOI":"10.1371\/journal.pone.0063344","article-title":"Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice","volume":"8","author":"Todoroff","year":"2013","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2014.09.024_bib0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.imlet.2011.12.006","article-title":"CpG oligonucleotides induce the differentiation of CD4(+)Th17 cells by triggering plasmacytoid dendritic cells in adoptively cell transfer immunotherapy","volume":"142","author":"Xu","year":"2012","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0255","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1086\/344359","article-title":"Investigation of the relationship between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity","volume":"186","author":"Hoft","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0260","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.4049\/jimmunol.171.9.4689","article-title":"CD4+ T cells mediate IFN-\u03b3-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo","volume":"171","author":"Cowley","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2014.09.024_bib0265","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2249.2012.04614.x","article-title":"Is interferon-gamma the right marker for bacille Calmette-Gu\u00e9rin-induced immune protection? The missing link in our understanding of tuberculosis immunology","volume":"169","author":"Abebe","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2014.09.024_bib0270","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.4049\/jimmunol.0903332","article-title":"Essential role of IL-17A in the formation of a mycobacterial Infection induced granuloma in the lung","volume":"184","author":"Okamoto Yoshida","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2014.09.024_bib0275","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/imm.12130","article-title":"Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of Mycobacterium tuberculosis infection","volume":"140","author":"Freches","year":"2013","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.vaccine.2014.09.024_bib0280","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/ni.1899","article-title":"Effector T cell plasticity: flexibility in the face of changing circumstances","volume":"11","author":"Murphy","year":"2010","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2014.09.024_bib0285","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.4049\/jimmunol.173.7.4433","article-title":"Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells","volume":"173","author":"Moseman EA1","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2014.09.024_bib0290","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.imlet.2006.12.007","article-title":"CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells","volume":"108","author":"LaRosa","year":"2007","journal-title":"Immunol Lett"},{"issue":"9","key":"10.1016\/j.vaccine.2014.09.024_bib0295","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/eji.201040484","article-title":"A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL\/6 mice","volume":"40","author":"Wu","year":"2010","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2014.09.024_bib0300","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1051\/medsci\/2007234379","article-title":"New routes of administration: epidermal, transcutaneous mucosal ways of vaccination","volume":"23","author":"Denis","year":"2007","journal-title":"Med Sci (Paris)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14012833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14012833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T13:57:26Z","timestamp":1689515846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14012833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":60,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0264410X14012833"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.09.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HBHA vaccination may require both Th1 and Th17 immune responses to protect mice against tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}